Cure8 research brief
The study suggests stromal fibroblasts can drive pro-inflammatory neutrophil programs in ulcerative colitis and that targeting fibroblast-associated pathways may reduce neutrophil-driven inflammation—information that could guide new therapeutic approaches and biomarkers.
Researchers studying IBD pathogenesis or stromal-immune interactions, translational scientists developing stromal-targeting therapies, and clinicians interested in emerging mechanisms that could lead to new treatments or biomarkers.
The study integrates human and mouse colonic single-cell RNA-seq, spatial protein profiling, in vitro coculture, and mouse DSS colitis with fibroblast ablation or α5β1-directed treatment.
Inflamed UC tissue and fibroblast-exposed neutrophils showed higher markers such as OSM and CXCR4 and increased NET-associated elastase activity; both genetic ablation of FAP+ fibroblasts in mice and pharmacologic 5β1 blockade reduced overall neutrophil frequency and histologic inflammation, though they had different effects on neutrophil subsets and epithelial responses.
The findings point to stromal–neutrophil interactions as a potential therapeutic axis in UC and suggest that measuring both neutrophil phenotype and tissue inflammation could help evaluate stromal-directed therapies.
Preprint on bioRxiv; results combine human tissue profiling and mouse/experimental models. Clinical implications are preliminary until validated in peer review and human trials.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Identifying an RNF213-marked Treg subset may help researchers understand immune mechanisms active in UC and could lead to new biomarker or therapeutic targets in the future.
Researchers and clinicians interested in UC biology may find new candidate biomarkers and cell-type–specific transcriptional programs that link iron-related aging processes to mucosal inflammation and tissue remodeling.
Researchers identified molecular features of a proposed “ferro‑aging” state in UC and nominated CHST15 and MSN as biomarkers, which could help understand disease biology and point to new experimental targets for therapy...
